Coya Therapeutics, Inc.
Ticker: 1835022
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q2 FY2024 | Q1 FY2024 |
|---|---|---|---|---|---|---|
| INCOME | ||||||
| Revenue | 0.25-93.0% | 3.56+2125.0% | 0.16-38.5% | 0.26-92.4% | 3.43+2538.5% | 0.13 |
| Total Income | 0.25-93.0% | 3.56+2125.0% | 0.16-38.5% | 0.26-92.4% | 3.43+2538.5% | 0.13 |
| EXPENSES | ||||||
| Expenditure | 7.89+31.5% | 6.00-8.8% | 6.58-17.0% | 7.93+19.1% | 6.66+18.7% | 5.61 |
| Tax | — | — | 0.00 | — | — | — |
| PROFIT | ||||||
| PBT | -7.21 | — | -6.09+16.7% | -7.31 | — | — |
| Net Profit | -7.21-240.1% | -2.12+65.2% | -6.09+16.7% | -7.31-152.9% | -2.89+42.8% | -5.05 |
| KEY METRICS | ||||||
| OPM % | -100.00%-31.74pp | -68.26%+31.74pp | -100.00% | -100.00%-5.52pp | -94.48%+5.52pp | -100.00% |
| NPM % | -100.00%-40.64pp | -59.36%+40.64pp | -100.00% | -100.00%-15.58pp | -84.42%+15.58pp | -100.00% |
| EPS | -0.32-146.2% | -0.13+63.9% | -0.36+18.2% | -0.44-131.6% | -0.19+45.7% | -0.35 |
Corporate Events
Board MeetingCOYA
202625Jun
Board Meeting
Annual Meeting of Stockholders to elect two Class I director…
SEC Filing ↗